#LeukemiaResearch
LightNews LightNews
oncodaily.bsky.social
OncoInfluencers to Follow on Social Media: Fadi Haddad
@mdanderson.bsky.social

oncodaily.com/career/fadi-...

#Cancer #LeukemiaResearch #LinkedIn #OncoDaily #Oncoinfluencer #OncoinfluencersToFollow #Oncology #MDAnderson #Medicine #Health
OncoInfluencers to Follow on Social Media: Fadi Haddad - OncoDaily
OncoInfluencers to Follow on Social Media: Fadi Haddad / cancer, Fadi Haddad, Leukemia Research, LinkedIn, OncoDaily, oncoinfluencer, Oncoinfluencers to
oncodaily.com
December 24, 2024 at 5:29 PM
jeremiaslab.bsky.social
📢 We’re heading to Dublin!

Irmela Jeremias will be attending the 4th Translational Research Conference: Acute Lymphoblastic Leukaemia (ALL).

We’re excited to share our latest research during the poster session.

#ESHALL2025 #LeukemiaResearch #CRISPR #PDXmodels #TranslationalResearch
May 21, 2025 at 2:43 PM
boierslab.bsky.social
Don’t miss our new preprint!
We mapped chromatin accessibility in human first-trimester HSPCs, revealing key fetal vs adult differences in hematopoiesis.
🔗 doi.org/10.64898/202...
#Hematopoiesis #StemCells #Chromatin #Epigenetics #LeukemiaResearch
Chromatin Accessibility Shapes Developmental-Specific Lineage Plasticity in Hematopoiesis
Cell differentiation is governed by dynamic changes in chromatin accessibility, and its dysregulation underlies multiple disease states. Prior to birth, development of the hematopoietic system constit...
doi.org
December 12, 2025 at 11:01 AM
schuhlab.bsky.social
Don't miss Hannah Uckelmann's talk today on targeting epigenetic regulators in leukemia development! ▶️ At 3pm @mpi-nat.bsky.social Join us for a compelling session! @hannahuckelmann.bsky.social #leukemiaresearch #epigenetics
MPI-NAT Seminar: Targeting epigenetic regulators in leukemia development
2025, Max-Planck-Gesellschaft
www.mpinat.mpg.de
March 20, 2025 at 7:50 AM
stevestonedraws.bsky.social
Dr. Maggie Ferris dives into AML biology:
🧬 RXR & KMT2A/C play key roles
⚡️ ATRA works for acute promyelocytic leukemia
💡 MENIN inhibition strategies for MLL-rearranged AML
Can we combine ATRA + Bexarotene?
#LeukemiaResearch #PedsOnc #AML
May 23, 2025 at 2:47 AM
gibbonsrun.bsky.social
🏃‍♀️🏃‍♂️ Attending #ASCO25?

🌅 Start your day along Chicago's beautiful lakefront—all while supporting life-saving #leukemiaresearch.

📅 When: Saturday, May 31 at 8:30 AM
📍 Where: Montrose Harbor, Chicago

🔗 Sign up now through the link in our bio.

#LaceUp4Leukemia #Cancer #Oncology
January 16, 2025 at 9:11 PM
leukemiaresearch.bsky.social
We’re thrilled to announce the 2025–2027 New Investigator Research Grant recipients—13 outstanding scientists from across the country who are pushing the boundaries of leukemia research.

Meet the 2025–2027 awardees: bit.ly/474sfGP

#LeukemiaResearch #ScientificDiscovery #FundingtheFuture
The Leukemia Research Foundation announces 2025-2027 research grant recipients
Northfield, IL - The Leukemia Research Foundation is pleased to announce the recipients of the 2025-2027 New Investigator Research Grant Program. Grants
bit.ly
July 31, 2025 at 9:16 PM
ciprianstefan.bsky.social
https://open.substack.com/pub/stefanodangello/p/together-we-can-bring-hope
#BloodCancer #LeukemiaAwareness #CancerFighter #LeukemiaSurvivor #FightLeukemia #CancerWarrior #HopeForLeukemia #LeukemiaResearch #LeukemiaSupport #EndLeukemia
July 9, 2025 at 4:36 AM
lundstem.bsky.social
🎗️What causes childhood leukemia to develop?

With funding from Barncancerfonden, 3 early-career researchers at Lund Stem Cell Center are investigating the origins & progression of the disease.

Read more in our full Q&A:
www.stemcellcenter.lu.se/article/thre...

#ChildhoodCancer #LeukemiaResearch
Three researchers receive Barncancerfonden funding to investigate the causes of childhood leukemia
Lund University. This spring Barncancerfonden, the Swedish Childhood Cancer Foundation, awarded SEK 64 million to 29 researchers across the country. The funding includes positions of up to six years f...
www.stemcellcenter.lu.se
July 14, 2025 at 12:15 PM
leukemiaresearch.bsky.social
We are grateful for all of the researchers who are making a difference in the lives of so many people impacted by leukemia. Happy Thanksgiving from the Leukemia Research Foundation.
#LeukemiaResearch #ThankYouResearchers
November 27, 2025 at 4:01 PM
comazzettolab.bsky.social
If you want to contribute to ground breaking discoveries in pediatric leukemia in a collaborative and vibrant team, come join us at the Centre for Regenerative Medicine in Edinburgh. #ResearchJobs #CancerResearch #LeukemiaResearch #PediatricCancer
elxw.fa.em3.oraclecloud.com/hcmUI/Candid...
May 7, 2026 at 10:23 AM
faseborg.bsky.social
Exciting T-ALL research from The #FASEBJournal. 🔬 Scientists discovered how to force leukemia cells to "grow up" and die naturally using KLF4 protein. Drug APTO-253 shows promise for gentler childhood cancer treatments.
Read full study: buff.ly/nl3jA0d
#LeukemiaResearch #PedatricCnacer
May 26, 2025 at 6:37 PM
shihcheng.bsky.social
Carfilzomib might be key for ibrutinib-resistant CLL! Mouse model shows aggressive relapse. Omics: exon, transcript, proteome data back it up. #LeukemiaResearch PMID:39863584, Nat Commun 2025, @NatureComms https://doi.org/10.1038/s41467-025-56318-7 #Medsky 🧪
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL | Nature Communications
Chronic lymphocytic leukemia is a malignant lymphoproliferative disorder for which primary or acquired drug resistance represents a major challenge. To investigate the underlying molecular mechanisms, we generate a mouse model of ibrutinib resistance, in which, after initial treatment response, relapse under therapy occurrs with an aggressive outgrowth of malignant cells, resembling observations in patients. A comparative analysis of exome, transcriptome and proteome of sorted leukemic murine cells during treatment and after relapse suggests alterations in the proteasome activity as a driver of ibrutinib resistance. Preclinical treatment with the irreversible proteasome inhibitor carfilzomib administered upon ibrutinib resistance prolongs survival of mice. Longitudinal proteomic analysis of ibrutinib-resistant patients identifies deregulation in protein post-translational modifications. Additionally, cells from ibrutinib-resistant patients effectively respond to several proteasome inhi
doi.org
March 10, 2025 at 1:10 PM
currentmedscience.bsky.social
#ATF6 inhibition, in combination with #Doxorubicin, represents a promising therapeutic approach to enhance #Apoptosis in BCP-ALL cells, highlighting new directions for #leukemia therapy #medsky

To read: doi.org/10.1007/s115...

#currentmedicalscience #Oncology #LeukemiaResearch
ATF6 Identification Sensitizes B-Cell Precursor Acute Lymphoblastic Leukemia Cells to Doxorubicin
August 12, 2026 at 7:00 AM
jcvi.org
an approach designed to attack cancer cells while enhancing anti-tumor immunity.
#ConquerKidsCancer #ChildhoodCancer #LeukemiaResearch #StBaldricks

www.jcvi.org/media-center...
J. Craig Venter Institute awarded $200,000 St. Baldrick’s Foundation grant to advance childhood leukemia treatment
LA JOLLA, California—July 23, 2026—The J. Craig Venter Institute (JCVI) today announced it has received a two-year, $200,000 Emily Beazley Kures...
www.jcvi.org
July 23, 2026 at 4:07 PM
hemehub.bsky.social
🩸Happening on Friday!

🔗Register: hemehub.org/live-webinars
📝Submit your cases: hemehub.org/case-submiss...

#CMML #ChronicMyelomonocyticLeukemia #MyeloidMalignancies #Hematology #LeukemiaResearch #MedicalEducation #CaseBasedLearning #HemeOnc #ClinicalInsights
hemehub.bsky.social hemehub.bsky.social @hemehub.bsky.social · Apr 27
🩸Join us for an expert-led session with Dr. Daniel Wiseman (The Christie NHS Foundation Trust) and Dr. Moaath Mustafa Ali (@clevelandclinic.bsky.social) on CMML.

🔗Register: hemehub.org/live-webinars
💭Submit your cases: hemehub.org/case-submiss...

#CMML #Hematology #Leukemia #MedEd #HemeOnc
May 6, 2026 at 7:32 PM
hemehub.bsky.social
🩸Happening this Friday!

🔗Register: hemehub.org/live-webinars
📝Submit your cases: hemehub.org/case-submiss...

#CMML #ChronicMyelomonocyticLeukemia #MyeloidMalignancies #Hematology #LeukemiaResearch #MedicalEducation #CaseBasedLearning #HemeOnc #ClinicalInsights
hemehub.bsky.social hemehub.bsky.social @hemehub.bsky.social · Apr 27
🩸Join us for an expert-led session with Dr. Daniel Wiseman (The Christie NHS Foundation Trust) and Dr. Moaath Mustafa Ali (@clevelandclinic.bsky.social) on CMML.

🔗Register: hemehub.org/live-webinars
💭Submit your cases: hemehub.org/case-submiss...

#CMML #Hematology #Leukemia #MedEd #HemeOnc
May 5, 2026 at 12:39 AM
hemehub.bsky.social
🩸 Further insights on treatment options for CMML

#CMML #MyeloidMalignancies #Hematology #LeukemiaResearch #RASMutations #KRASInhibitors #TargetedTherapy #PanRAS #Immunotherapy #TIM3 #LILRB4 #MDSMPN #ClonalEvolution #MedicalEducation #HemeOnc #HEMEHUB
April 27, 2026 at 7:47 PM
sharifimohm.bsky.social
Research found two small RNAs are more active in leukemia, potentially aiding early diagnosis. #LeukemiaResearch #Biomarkers
www.rimpacts.com/rd/p?c=10160...
Investigation of the Expression of P-Element-Induced Wimpy Testis-Interacting Rnas in Human Acute Myeloid Leukemia
Research found two small RNAs are more active in leukemia, potentially aiding early diagnosis. #LeukemiaResearch #Biomarkers
www.rimpacts.com
November 6, 2025 at 1:38 PM
jeremiaslab.bsky.social
🔬Dhruv Mehra
“PDX models from diagnosis–relapse pairs of pediatric T-ALL”

🔬 Siddhi Pawar
“LIMS1 is a new therapeutic target for acute myeloid leukemia”

Looking forward to great science, inspiring discussions, and new collaborations!

#PediatricOncology #LeukemiaResearch #AML #TALL #Wilsede
June 3, 2026 at 12:49 PM
currentmedscience.bsky.social
This study demonstrates that circ_0012152 promotes #AML cell proliferation through the miR-652-3p/SOX4 axis and serves as an independent poor prognostic factor for overall survival. #LeukemiaResearch #medsky

Read more: link.springer.com/article/10.1...
October 18, 2025 at 9:31 AM
childrensresearch.bsky.social
Dr. Matt Witkowski has received an R37 MERIT award to extend his leukemia research looking at how to improve treatment outcomes for pediatric cancer patients who relapse after advanced therapies. #LeukemiaResearch #PediatricCancer #OncSky
MERIT Award Fuels Pediatric Leukemia Research
Exploring reasons behind treatment resistance in leukemia.
www.childrenscolorado.org
August 25, 2025 at 2:17 PM
handle.invalid
Scientists reprogram leukemia cells to combat AML—discover the groundbreaking therapy offering new hope. #LeukemiaResearch #CancerTherapy #AMLBreakthrough
Reprogramming Leukemia: A New Frontier in AML Treatment
Scientists reprogram leukemia cells to combat AML—discover the groundbreaking therapy offering new hope.
geekoo.news
April 22, 2025 at 5:00 AM
handle.invalid
A key protein has a hidden role fueling leukemia. Scientists say this discovery could lead to smarter, more effective treatments. #LeukemiaResearch #CancerBreakthrough #TargetedTherapies
Hidden Role of Key Protein Could Transform Leukemia Treatment
Northwestern researchers discovered a hidden metabolic role for Menin in leukemia—offering a powerful new target for more effective, personalized treatments.
geekoo.news
March 25, 2025 at 12:01 PM
gpbees.bsky.social
HematoMap provides a systematic framework to infer leukemic cell origins and visualize cellular composition changes within the normal hematopoietic hierarchy.

It helps reveal how leukemia cells diverge from expected lineage trajectories.

#Hematopoiesis #LeukemiaResearch
April 28, 2026 at 1:38 AM